ONC SCHEDULE 13D/A: SEC filing
Baker Brothers Life Sciences, L.P. and affiliated entities
Filed with the SEC on · accession 0001104659-26-108269
ONC filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Sep 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +0.5% by the first close after the filing.
Summary of the filing
Baker Brothers Life Sciences, L.P. and affiliated entities filed an amended Schedule 13D reporting beneficial ownership of 114,387,735 ordinary shares, or 7.7% of BeOne Medicines Ltd.'s outstanding class.
Key details
How ONC stock reacted
Close before
$346.50
Sep 15, 2026
First close after
+0.46%
$348.08
5 trading days
+6.23%
$368.08
Since filing
+11.76%
$387.25
✦ Ask GOAX AI about this filing — what it means for ONC, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ONC?
Click hereFrequently asked questions
What did ONC file with the SEC on Sep 16, 2026?
ONC filed a SCHEDULE 13D/A (SEC filing). Baker Brothers Life Sciences, L.P. and affiliated entities filed an amended Schedule 13D reporting beneficial ownership of 114,387,735 ordinary shares, or 7.7% of BeOne Medicines Ltd.'s outstanding class.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did ONC stock react to this filing?
ONC closed at $346.50 before the filing and $348.08 on Sep 16, 2026 (+0.46%). Five trading days later: $368.08 (+6.23%).
Other ONC SEC filings
- 8-K · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingAug 26, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · SEC filingAug 5, 2026
- 144 · Insider sale plannedJul 10, 2026
- 144 · Insider sale plannedJul 10, 2026
- 8-K · Regulatory actionJun 26, 2026
- 8-K · SEC filingJun 11, 2026
- 8-K · Fda approvalMay 15, 2026
Get alerts when ONC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days